Skip to content
thestock.space

Johnson Pharmacare (BSE: JOHNPHARMA) is loss-making over the last 12 months, losing ₹57 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹0.45, 36% below its 52-week high. Debt is 49.18× equity. It is a small-cap company with a market cap of ₹25 Cr, ranked 4th of 19 Shell Companies companies by market cap; the shares fell 31% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹0.45
Day high
₹0.46
Day low
₹0.42
Prev. close
₹0.45
Volume
6.5 L

Health check

5 to check
  • ReturnsBehind

    −30.8% over a year, better than 2 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • Growthn/a

    Not enough yearly results to measure.

  • ProfitabilityNegative

    ROCE -254.0% vs peer median -10.7%.

  • Balance sheetStretched

    Debt 49.18× equity, operating profit doesn’t cover interest, Piotroski 2 of 9.

  • Red flags5 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Shell Companies

18 listed peers. Screen the industry

Small cap

₹25 Cr, #4 of 19 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹2 Cr · profit ₹−57 Cr
Market cap
₹25 Cr
Small cap
P/E
n/a
Industry 12.1
Price to book
56.25
Peers 11.31
Dividend yield
0.00%
ROE
−196.9%
Peers 1.0%
ROCE
−254.0%
Peers −10.7%
Debt to equity
49.18
Debt ₹21 Cr
EPS (TTM)
−₹1.03
OPM (TTM)
−2605.3%
Net margin 0.0%
Sales growth
n/a
Year-ago quarter not reported
Profit growth
n/a
Year-ago quarter not reported
Price to sales
15.65

Strengths and risks

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at −196.9%.
  • Debt is 49.18× equity.
  • 36% below its 52-week high.
  • Interest coverage of only −163.3×.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Johnson Pharmacare

Johnson Pharmacare Limited does not have significant operations. Previously, the company was engaged in the trading of shares and other investments. The company was formerly known as Sun And Shine Worldwide Limited and changed its name to Johnson Pharmacare Limited in August 2021. Johnson Pharmacare Limited was incorporated in 1994 and is based in Ahmedabad, India.

Headquarters
Ahmedabad
Sector
Financial Services
ISIN
INE560F01022

Price range

52 weeks

₹0.36₹0.70

Today

₹0.42₹0.46
Avg volume (3M)
9.2 L
1-year return
minus 30.8%
From 52-week high
minus 35.7%

Peers · Shell Companies

Company
BLALBEML Land Assets164.97minus 1.00%687–613.27−16.4%1.0%64.8%–0.00%minus 19.7%
MELSTARMelstar Information Technologies382.01plus 5.00%107–20.85−43.4%−6.1%58.0%–0.00%plus 8460.5%
INFOMEDIAInfomedia Press5.42minus 2.34%27–−0.436.6%–90.0%–0.00%minus 26.9%
JOHNPHARMAJohnson Pharmacare0.450.00%25–56.25−254.0%−196.9%−2605.3%–0.00%minus 30.8%
CHMBBRWChambal Breweries & Distilleries32.40minus 4.99%24–29.59−25.1%−20.2%−817.6%–0.00%minus 22.7%
BOMBWIRBombay Wire Ropes37.00minus 1.54%206.81.77−0.9%31.2%−29.2%–0.00%minus 33.2%
MDRNSTLModern Steels12.80plus 3.14%1812.10.93−5.0%5.7%0.0%−57.6%0.00%minus 25.8%
TECILCHEMTECIL Chemicals and Hydro Power8.18minus 2.62%16––––0.0%–0.00%minus 59.1%
Median of 7 peers–−1.54%249.411.31−10.7%1.0%0.0%−57.6%0.00%−25.8%

Quarterly results

Consolidated, ₹ crore
Operating profit (EBITDA)Select a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
−0.1−0−0−42.7−0
0001.60
––00.21.1
–––−14.3–
−0.1−0−0.1−55.6−1.1
−0.1−0−0.1−55.6−1.1
–––-1.01-0.02

Profit & loss

Yearly, ₹ crore
ROE
−196.9%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2.5–––
2.3–––
0.2−0.2−0.1−42.8
8.8%–––
−0−0−0.31.6
–––0.3
−1.6–−0.2−14.3
−1.3−0.2−0.6−55.7
2.9%–––
−1.3−0.2−0.6−55.7
-0.02–-0.01-1.01

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
55555555
1.91.81.2−54.6
1.920.621.4
11.11.20.2
59.859.857.922
45.645.642.319.7
0000.1
14.314.315.62.2
59.859.857.922

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−0.4−0−1.9−57.6
−0.903.336.8
1.3–−1.320.8
−0−000.1
−0.4−0−1.9−57.6

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you